Raymond Adamcik — Florida AntiAging Center
GLP‑1 analogs (such as semaglutide and liraglutide) are emerging as powerful therapies that extend well beyond glucose control. Research shows potential neuroprotection, cardiovascular risk reduction, and kidney protection, making them an important option for patients focused on long‑term multi‑system health. At the Florida AntiAging Center, we evaluate each patient’s medical history and goals to determine whether GLP‑1 therapy may improve metabolic health, protect vital org